Pere Santamaria

Professor, Department of Microbiology, Immunology & Infectious Diseases · Diabetes Canada

Looking at the immunogenetics and immunopathogenesis of autoimmune disorders, with a particular focus on type 1 diabetes.

Therapeutic Intervention Autoimmune Diseases Type 1 Diabetes Immunogenetics

Stan Gee Louie, PharmD

Professor of Clinical Pharmacy & Director of Clinical Experimental Therapeutics Program · USC School of Pharmacy

Stan Gee Louie is a clinical and translational pharmacologist with three decades of clinical and drug development experience.

Accelerating wound healing properties Developing novel drug therapy to inhibit chronic inflammation in cancer, diabetes, and neurodegenerative disease. Drug development targeting viral infection and cancer. Metabolomic approaches to dissecting the molecular mechanism(s) driving pharmacologic responses.

Sarah F. Hamm-Alvarez, PhD

Professor of Pharmacology and Pharmaceutical Sciences · USC School of Pharmacy

Sarah F. Hamm-Alvarez is an expert in drug delivery for eye diseases.

Cellular Junctions Autoimmune Diseases Cytoskeleton Trafficking Membrane Trafficking Lacrimal Gland (Tear Gland)

Scott Requadt

CEO · Talaris Therapeutics

Scott Requadt has operating and investment experience in the biopharmaceutical industry including therapeutics, medtech and diagnostics.

Entrepreneurship Corporate Development Life Sciences Biotechnology Venture Capital

J. Andrew MacKay, PhD

Associate Professor of Pharmacology and Pharmaceutical Sciences · USC School of Pharmacy

J. Andrew MacKay engineers innovative protein-polymer tools and drug carriers that respond to the environment.

Ocular Drug Delivery Pharmacokinetics Elastin-like Polypeptides Protein Polymers Biomolecular Engineering

Robert Garry

Professor · Tulane University

Dr. Garry has published over 100 papers in the area of retrovirology

COVID-19 Pathology Lassa Fever Molecular Mechanisms of Viral Pathogenesis Ebola